These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 35897006)

  • 1. Safety and efficacy of low-dose rt-PA with tirofiban to treat acute non-cardiogenic stroke: a single-center randomized controlled study.
    Liang Z; Zhang J; Huang S; Yang S; Xu L; Xiang W; Zhang M
    BMC Neurol; 2022 Jul; 22(1):280. PubMed ID: 35897006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early tirofiban administration for patients with acute ischemic stroke treated with intravenous thrombolysis or bridging therapy: Systematic review and meta-analysis.
    Liu Q; Lu X; Yang H; Deng S; Zhang J; Chen S; Shi S; Xun W; Peng R; Lin B; Li T; Pan L; Weng B
    Clin Neurol Neurosurg; 2022 Nov; 222():107449. PubMed ID: 36162161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-Dose Tirofiban Treatment Improves Neurological Deterioration Outcome After Intravenous Thrombolysis.
    Wu C; Sun C; Wang L; Lian Y; Xie N; Huang S; Zhao W; Ren M; Wu D; Ding J; Song H; Wang Y; Ma Q; Ji X
    Stroke; 2019 Dec; 50(12):3481-3487. PubMed ID: 31570084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tirofiban for Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis: A Systematic Review and Meta-Analysis.
    Shi H; Hou MM; Ren G; He ZF; Liu XL; Li XY; Sun B
    Cerebrovasc Dis; 2023; 52(5):587-596. PubMed ID: 36580906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Efficacy and Safety of Tirofiban Use in Endovascular Thrombectomy for Intravenous Thrombolysis Applicable Patients with Large Vessel Occlusion Stroke-a Post Hoc Analysis from the Direct-MT Trial.
    Zhang Y; Zhang P; Tao A; Wang X; Ying J; Wang Z; Yang P; Zhang Y; Zhang L; Li Z; Zhang M; Xu C; Liu J;
    Cardiovasc Intervent Radiol; 2024 Feb; 47(2):208-215. PubMed ID: 37798430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous thrombolysis in acute ischemic stroke patients with cerebral microbleeds and analysis of risk factors for hemorrhagic transformation.
    Lei YS; Li H; Lei JY; Li SX; Li DF
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):779-786. PubMed ID: 35179744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review.
    Stan A; Dragos H; Strilciuc S; Ilut S; Vacaras V; Cozma A; Panaitescu PS; Stan H; Muresanu DF
    CNS Neurol Disord Drug Targets; 2023; 22(10):1493-1506. PubMed ID: 36200200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early tirofiban administration after intravenous thrombolysis in acute ischemic stroke (ADVENT): Study protocol of a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Guo ZN; Zhang KJ; Zhang P; Qu Y; Abuduxukuer R; Nguyen TN; Chen HS; Yang Y
    Eur Stroke J; 2024 Jun; 9(2):510-514. PubMed ID: 38196129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the efficacy and safety of tirofiban in patients with acute ischaemic stroke undergoing mechanical thrombectomy.
    Liu C; Yang X; Liu M; Wang J; Li G
    Clin Neurol Neurosurg; 2023 May; 228():107702. PubMed ID: 37058772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of Tirofiban During Mechanical Thrombectomy for Stroke Patients with Preceding Intravenous Thrombolysis.
    Huo X; Yang M; Ma N; Gao F; Mo D; Li X; Wang A; Wang Y; Miao Z
    Clin Interv Aging; 2020; 15():1241-1248. PubMed ID: 32801672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tirofiban for Stroke without Large or Medium-Sized Vessel Occlusion.
    Zi W; Song J; Kong W; Huang J; Guo C; He W; Yu Y; Zhang B; Geng W; Tan X; Tian Y; Liu Z; Cao M; Cheng D; Li B; Huang W; Liu J; Wang P; Yu Z; Liang H; Yang S; Tang M; Liu W; Huang X; Liu S; Tang Y; Wu Y; Yao L; Shi Z; He P; Zhao H; Chen Z; Luo J; Wan Y; Shi Q; Wang M; Yang D; Chen X; Huang F; Mu J; Li H; Li Z; Zheng J; Xie S; Cai T; Peng Y; Xie W; Qiu Z; Liu C; Yue C; Li L; Tian Y; Yang D; Miao J; Yang J; Hu J; Nogueira RG; Wang D; Saver JL; Li F; Yang Q;
    N Engl J Med; 2023 Jun; 388(22):2025-2036. PubMed ID: 37256974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial.
    Pancioli AM; Broderick J; Brott T; Tomsick T; Khoury J; Bean J; del Zoppo G; Kleindorfer D; Woo D; Khatri P; Castaldo J; Frey J; Gebel J; Kasner S; Kidwell C; Kwiatkowski T; Libman R; Mackenzie R; Scott P; Starkman S; Thurman RJ;
    Stroke; 2008 Dec; 39(12):3268-76. PubMed ID: 18772447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of a new modified intravenous recombinant tissue plasminogen activator (rt-PA) regimen in Chinese patients with acute ischemic stroke: A descriptive retrospective cohort study with subgroup-analysis of different rt-PA dose.
    Luo Y; Li J; Huang L; Liu X; Zhang B; Lin J; Jiang A; Zhao J
    J Clin Neurosci; 2022 Jul; 101():244-251. PubMed ID: 35653882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between intravenous tirofiban and intracranial hemorrhage in acute large vessel occlusion stroke: insight from the RESCUE BT randomized placebo-controlled trial.
    Sang H; Huang J; Jiang B; Guo Q; Nguyen TN; Abdalkader M; Han Q; Zhou S; Tao Z; Mao A; Yan Z; Du J; Jin Y; Huang C; Liu T; Zhao W; Gu G; Wang L; Liu S; Luo S; Pu J; Hu J; Yang J; Li F; Zi W; Hu X; Qiu Z
    J Neurol; 2023 Apr; 270(4):2246-2255. PubMed ID: 36697890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous intravenous tirofiban can improve the 90-day functional outcome and decrease 90-day mortality without increasing bleeding risk in acute ischemic stroke patients treated by endovascular therapy: A meta-analysis.
    Zhang A; Wu N; Liu X; Jiang T
    J Clin Neurosci; 2022 May; 99():109-116. PubMed ID: 35278931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nomogram to Predict Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke in Asian Population.
    Xie X; Yang J; Ren L; Hu S; Lian W; Xiao J; Pan L; Deng L; Ma J
    Curr Neurovasc Res; 2021; 18(5):543-551. PubMed ID: 34951382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
    Kwon JH; Shin SH; Weon YC; Hwang JC; Baik SK
    Neuroradiology; 2011 Oct; 53(10):779-85. PubMed ID: 21808986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of tirofiban combined with intravenous thrombolysis and endovascular treatment in acute large vessel occlusion stroke.
    Su S; Bai X; Li Q; Yue C; Yang J; Huang J; Kong W; Guo C; Hu J; Liu S; Yang D; Song J; Peng Z; Li L; Tian Y; Li F; Zi W; Liu X
    Clin Neurol Neurosurg; 2024 Sep; 244():108463. PubMed ID: 39053321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of serum MDA and 4-HNE levels on the occurrence of early neurological deterioration after intravenous thrombolysis with rt-PA IVT in patients with acute ischemic stroke.
    Zhang L; Li D; Zhang C; Zhang J; Xu J; Bai L; Xu J; Wang C
    J Stroke Cerebrovasc Dis; 2024 Apr; 33(4):107574. PubMed ID: 38214238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.